Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS-MEDICINE, RESEARCH & EXPERIMENTAL
Journal of Cardiovascular Translational Research
ISSN 1937-5387 · eISSN 1937-5395 · Springer US · UNITED STATES · 6 issues per year · Founded 2008
Journal of Cardiovascular Translational Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.56; hybrid open access; APC about USD 4,390; median 121 days to acceptance (99 articles, last 24 months); 135 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Cardiovascular Translational Research is published by Springer US and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cardiovascular Function and Risk Factors, Cardiac Valve Diseases and Treatments and Cardiac Imaging and Diagnostics, together about 20.9% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine and Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Cardiovascular Translational Research (JCTR) is a premier journal in cardiovascular translational research. JCTR is the journal of choice for authors seeking the broadest audience for emerging technologies, therapies and diagnostics, pre-clinical research, and first-in-man clinical trials. JCTR's intent is to provide a forum for critical evaluation of the novel cardiovascular science, to showcase important and clinically relevant aspects of the new research, as well as to discuss the impediments that may need to be overcome during the translation to patient care. JCTR encourages submission of original articles, reports on study designs, and review articles. • Authors receive a decision within 10 days, on average• Fast OnlineFirst publication ahead of print• For more information including details on article submission, please visit http://www.springer.com/12265
From the journal's Aims & Scope
Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS-MEDICINE, RESEARCH & EXPERIMENTAL
Editor-in-chief Enrique Lara-PezziPublisher website
Editorial board by country: 9 in mainland China (about 13%); most named United States 30, Mainland China 9, Spain 7, Italy 5, Netherlands 5 (67 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cardiovascular Function and Risk FactorsMedicine9.2%
- Cardiac Valve Diseases and TreatmentsMedicine5.9%
- Cardiac Imaging and DiagnosticsMedicine5.9%
- Cardiac Fibrosis and RemodelingMedicine5.7%
- Tissue Engineering and Regenerative MedicineMedicine5.4%
- Coronary Interventions and DiagnosticsMedicine5.2%
- Cardiac electrophysiology and arrhythmiasMedicine4.8%
- Cardiomyopathy and Myosin StudiesMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.56LetPub ·
- Impact factor (publisher) 2025
- 2.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.8Publisher website ·
- CiteScore 2026-06
- 5.3LetPub ·
- SJR 2026-06
- 0.8LetPub ·
- SNIP 2026-06
- 0.73LetPub ·
- h-index
- 44LetPub ·
- h-index
- 78OpenAlex ·
- i10-index
- 902OpenAlex ·
- 2-year mean citedness
- 2.45OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 29.85%LetPub ·
Volume
- Articles per year
- 123LetPub ·
- Downloads per year (publisher) 2025
- 527,800Publisher website ·
Articles by year OpenAlex count · 1,827 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 124 | 47 | 32 |
| 2025 | 135 | 43 | 371 |
| 2024 | 111 | 57 | 504 |
| 2023 | 128 | 54 | 981 |
| 2022 | 151 | 54 | 1,698 |
| 2021 | 100 | 36 | 1,388 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
121 daysMedian, submission to acceptance · P25–P75 71 days – 181 days
- Acceptance to online
- median 18 days (99 articles)
- Submission to online
- median 150 days
- Sample
- 99 articles with submission and acceptance dates (276 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Submission to first decision
- 12 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,390 / EUR 3,290 / GBP 2,790 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare7 items from the author guidelines
- Abstract
- ≤ 150 words
- Keywords
- ≤ 10
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted9, with length limits
- case studyReview – limited to 6000 words and 6 figures. Original Article – original research limited to 6000 words and 6 figures. Short Communication – limited to 800 wor…Length not stated
- editorialReview – limited to 6000 words and 6 figures. Original Article – original research limited to 6000 words and 6 figures. Short Communication – limited to 800 wor…Length not stated
- letter to the editorReview – limited to 6000 words and 6 figures. Original Article – original research limited to 6000 words and 6 figures. Short Communication – limited to 800 wor…Length not stated
- methods articleReview – limited to 6000 words and 6 figures. Original Article – original research limited to 6000 words and 6 figures. Short Communication – limited to 800 wor…main text ≤ 6,000 words
- opinionReview – limited to 6000 words and 6 figures. Original Article – original research limited to 6000 words and 6 figures. Short Communication – limited to 800 wor…Length not stated
- original articleReview – limited to 6000 words and 6 figures. Original Article – original research limited to 6000 words and 6 figures. Short Communication – limited to 800 wor…main text ≤ 6,000 words
- original researchReview – limited to 6000 words and 6 figures. Original Article – original research limited to 6000 words and 6 figures. Short Communication – limited to 800 wor…Length not stated
- reviewReview – limited to 6000 words and 6 figures. Original Article – original research limited to 6000 words and 6 figures. Short Communication – limited to 800 wor…main text ≤ 6,000 words
- short communicationReview – limited to 6000 words and 6 figures. Original Article – original research limited to 6000 words and 6 figures. Short Communication – limited to 800 wor…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability
The journal encourages authors to provide a statement of Data availability in their article. Data availability statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether data are av…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Journal of Cardiovascular Translational Research, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- 6 issues per year
- Founded
- 2008
- ISSN
- 1937-5387
- Electronic ISSN
- 1937-5395
- Society / sponsor
- International Society of Cardiovascular Translational Research
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Cardiovascular Translational Research
What CAS zone is Journal of Cardiovascular Translational Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Cardiovascular Translational Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Cardiovascular Translational Research?
The latest impact factor listed by LetPub is 2.56; CiteScore 5.3, h-index 78.
How long does peer review take at Journal of Cardiovascular Translational Research?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 121 days (interquartile range 71–181 days); authors report an average review time of 6–12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Cardiovascular Translational Research?
According to the journal's author guidelines: Abstract: ≤ 150 words; Keywords: ≤ 10; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Cardiovascular Translational Research based?
Of the 67 board members whose country the journal's board page names, 9 (about 13%) are in mainland China; the countries named most often are United States (30), Mainland China (9) and Spain (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Cardiovascular Translational Research?
According to LetPub and DOAJ records, Journal of Cardiovascular Translational Research is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and Embase; that list has not been checked against each database.
Is Journal of Cardiovascular Translational Research open access, and what is the APC?
Journal of Cardiovascular Translational Research is a hybrid journal. For open-access publication: APC about USD 4,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .